Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Actinogen Medical progresses in XanaMIA Phase 2b/3 trial for Alzheimer’s disease Actinogen Medical Limited (ASX: ACW) has announced a major milestone in its ongoing XanaMIA Phase 2b/3 clinical trial,… byPallavi MadhirajuDecember 9, 2024